Yu, Jinha Assistant Professor

Pharmaceutical Sciences/Industrial Pharmaceutical Science/Division of Pharmacy

유진하 프로필 사진

				
  • Pharmaceutical Science Building A(Appenzeller Hall) #201
  • 0232773028
  • Research Interests
Research Record
  • DMAP and TBPP-mediated synthesis of urea-substituted nucleobases and nucleosides Tetrahedron, 2023, v.140, 133472
    SCIE Scopus dColl.
  • Design, Synthesis, and Molecular Docking Analysis of Fluorinated MLN4924 Derivatives as Antiviral Agents Asian Journal of Organic Chemistry, 2023, v.12 no.11, e202300416
    SCIE Scopus dColl.
  • Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer Bioorganic Chemistry, 2023, v.131, 106274
    SCIE Scopus dColl.
  • Structure-Activity Relationship of Truncated 2,8-Disubstituted-Adenosine Derivatives as Dual A2A/A3 Adenosine Receptor Antagonists and Their Cancer Immunotherapeutic Activity JOURNAL OF MEDICINAL CHEMISTRY, 2023, v.66 no.17, 12249-12265
    SCIE Scopus dColl.
  • Synthesis of oligonucleotides containing 5′-homo-4′-selenouridine derivative and its increased resistance against nuclease Bioorganic and Medicinal Chemistry Letters, 2023, v.83, 129172
    SCIE Scopus dColl.
  • Design, Synthesis and Biological Evaluation of 1,3,5-Triazine Derivatives Targeting hA1 and hA3 Adenosine Receptor Molecules, 2022, v.27 no.13, 4016
    SCIE Scopus dColl.
  • [학술지논문] Structural optimization and biological evaluation of ML364 based derivatives as USP2a inhibitors Bioorganic Chemistry, 2024, v.145 no.00 , 107222-107222
    Scopus
  • [학술지논문] DMAP and TBPP-mediated synthesis of urea-substituted nucleobases and nucleosides TETRAHEDRON, 2023, v.140 no.0 , 133472-133472
    SCIE
  • [학술지논문] Design, Synthesis, and Molecular Docking Analysis of Fluorinated MLN4924 Derivatives as Antiviral Agents ASIAN JOURNAL OF ORGANIC CHEMISTRY, 2023, v.12 no.11 , 202300-202300
    SCIE
  • [학술지논문] Discovery of dioxo-benzo[b]thiophene derivatives as potent YAP-TEAD interaction inhibitors for treating breast cancer BIOORGANIC CHEMISTRY, 2023, v.131 no.0 , 106274-106274
    SCIE
  • [학술지논문] Structure-Activity Relationship of Truncated 2,8-Disubstituted-Adenosine Derivatives as Dual A2A/A3 Adenosine Receptor Antagonists and Their Cancer Immunotherapeutic Activity JOURNAL OF MEDICINAL CHEMISTRY, 2023, v.66 no.17 , 12249-12265
    SCIE
  • [학술지논문] Synthesis of oligonucleotides containing 5 '-homo-4 '-selenouridine derivative and its increased resistance against nuclease BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, v.83 no.0 , 129172-129172
    SCIE
  • [학술지논문] Design, Synthesis and Biological Evaluation of 1,3,5-Triazine Derivatives Targeting hA(1) and hA(3) Adenosine Receptor MOLECULES, 2022, v.27 no.13 , 4016-4016
    SCIE
Courses
  • 2024-1st

    • Pharmaceutical Synthesis Ⅱ

      • Subject No 33947Class No 01
      • 4Year ( 3Credit , 3Hour) Wed 2~2 (PHM-A404) , Fri 4~4 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅱ

      • Subject No 33947Class No 02
      • 4Year ( 3Credit , 3Hour) Mon 2~2 (PHM-A104) , Thu 2~2 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory IV

      • Subject No 37127Class No 01
      • 4Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A309)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory IV

      • Subject No 37127Class No 02
      • 4Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A309)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory IV

      • Subject No 37127Class No 03
      • 4Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A309)
      • Major Requisite
    • Honors research

    • Pharmaceutical Organic Chemistry Ⅰ

      • Subject No 38931Class No 01
      • 2Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A400) , Thu 4~4 (PHM-A100-1)
      • Major Requisite,Language Changed
    • Pharmaceutical Organic Chemistry Ⅰ

      • Subject No 38931Class No 02
      • 2Year ( 3Credit , 3Hour) Tue 2~2 (POSCO451) , Fri 2~2 (PHM-A104)
      • Major Requisite,Language Changed
    • Pharmaceutical Synthesis Ⅰ 강의 계획서 상세보기

      • Subject No 38947Class No 01
      • 3Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A104) , Wed 4~4 (PHM-A104)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅰ 강의 계획서 상세보기

      • Subject No 38947Class No 02
      • 3Year ( 3Credit , 3Hour) Wed 5~5 (PHM-A104) , Fri 6~6 (PHM-A404)
      • Major Requisite
    • Pharmaceutical Experiment Ⅰ

      • Subject No 38963Class No 01
      • 3Year ( 2Credit , 3Hour) Mon 6~9 (PHM-A309)
      • Major Requisite
    • Pharmaceutical Experiment Ⅰ

      • Subject No 38963Class No 02
      • 3Year ( 2Credit , 3Hour) Tue 6~9 (PHM-A309)
      • Major Requisite
    • Pharmaceutical Organic Chemistry Ⅰ

      • Subject No 39036Class No 01
      • 2Year ( 3Credit , 3Hour) Tue 2~2 (POSCO451) , Fri 2~2 (PHM-A104)
      • Major Requisite,Language Changed
    • Introduction to Pharmaceutical Research

      • Subject No 39045Class No 01
      • 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A100-1)
    • Pharmaceutical Synthesis Ⅰ 강의 계획서 상세보기

      • Subject No 39052Class No 01
      • 3Year ( 3Credit , 3Hour) Wed 5~5 (PHM-A104) , Fri 6~6 (PHM-A404)
      • Major Requisite
    • Pharmaceutical Experiment Ⅰ

      • Subject No 39068Class No 01
      • 3Year ( 2Credit , 3Hour) Wed 6~9 (PHM-A309)
      • Major Requisite
    • Advanced Medicinal Chemistry Ⅰ

      • Subject No G16861Class No 01
      • Year ( 3Credit , 3Hour) Wed 4~5 (PHM-A204)
  • 2023-2nd

  • 2023-1st

  • 2022-2nd

    • Pharmaceutical Synthesis Ⅲ

      • Subject No 33948Class No 01
      • 4Year ( 1.5Credit , 1.5Hour) Tue 4~4 (PHM-A100-1)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅲ

      • Subject No 33948Class No 02
      • 4Year ( 1.5Credit , 1.5Hour) Tue 3~3 (PHM-A100-1)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅲ

      • Subject No 33948Class No 03
      • 4Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A100-1)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅲ

      • Subject No 33948Class No 04
      • 4Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A100-1)
      • Major Requisite
    • Honors research

    • Lab rotation Ⅰ

      • Subject No 38927Class No 01
      • 1Year ( 1.5Credit , 0Hour) Thu 7~7
    • Lab rotation Ⅰ

      • Subject No 38927Class No 02
      • 1Year ( 1.5Credit Thu 7~7
    • Lab rotation Ⅰ

      • Subject No 39032Class No 01
      • 1Year ( 1.5Credit , 0Hour) Thu 7~7
    • Synthetic Medicinal Chemistry

      • Subject No G16901Class No 01
      • Year ( 3Credit , 3Hour) Wed 5~6 (PHM-)
  • 2022-1st

    • Pharmaceutical Synthesis Ⅱ

      • Subject No 33947Class No 01
      • 4Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A400) , Wed 3~3 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅱ

      • Subject No 33947Class No 02
      • 4Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A400) , Wed 4~4 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅱ

      • Subject No 33947Class No 03
      • 4Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A100-1) , Thu 6~6 (PHM-A400)
      • Major Requisite
    • Pharmaceutical Synthesis Ⅱ

      • Subject No 33947Class No 04
      • 4Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A100-1) , Thu 6~6 (PHM-A400)
      • Major Requisite
    • Advanced Medicinal Chemistry I

      • Subject No G16861Class No 01
      • Year ( 3Credit , 3Hour) Fri 5~6 (PHM-)
Academic Background

Ewha Womans University 약학박사(약학과)

Ewha Womans University 약학석사(생명/약학부)

Ewha Womans University 약학사(약학과)

Work Experience

한국과학기술연구원 (KIST) 2019-09-01 ~ 2022-02-28

서울대 2018-03-01 ~ 2019-08-31

National Institute of Health 2016-03-07 ~ 2018-02-23